Shares of Prothena Corporation plc (PRTA) soared on Wednesday after Danish drugmaker Novo Nordisk (NVO) said that it expects ...

Prothena Corporation plc (NASDAQ:PRTA), announced that Novo Nordisk communicated during their second quarter 2025 earnings call on August 6, 2025 that they expect to advance coramitug, a potential ...

Shares of Prothena climbed after Novo Nordisk said during its second-quarter earnings call that it expects to advance a treatment for amyloidosis it bought from Prothena in 2021. The Dublin company's ...

Novo Nordisk will advance its acquired ATTR amyloidosis with cardiomyopathy monoclonal antibody (mAb) to Phase III trials.

On August 6, 2025, Prothena announced that its partner Novo Nordisk will advance coramitug, a potential first-in-class amyloid depleter antibody, into Phase 3 development for ATTR amyloidosis with ...

Prothena today reported financial results for the second quarter and first six months of 2025 and provided business highlights.

In the assessment of 12-month price targets, analysts unveil insights for Prothena Corp, presenting an average target of $34.67, a high estimate of $81.00, and a low estimate of $4.00. Observing a ...

Return on Equity (ROE): Prothena Corp's ROE falls below industry averages, indicating challenges in efficiently using equity ...

DUBLIN (AP) — DUBLIN (AP) — Prothena Corp. (PRTA) on Monday reported a loss of $125.8 million in its second quarter. The Dublin-based company said it had a loss of $2.34 per share. Losses, adjusted ...

Prothena stock surged 34%, closing at 16.01. That pushed shares above their 50-day moving average for the first time since late September, according to MarketSurge.

Prothena's management team does have decades of experience, however, and excitement around PRX012 is likely justified, and even more so today thanks to the fresh "proof" that the amyloid beta ...

Prothena Corp.PRTA0.47%increase; green up pointing triangle said its Parkinson's disease treatment showed the ability to safely reduce a key protein potentially linked to the disease, in an early ...